@misc{indiciae9265400c776c,
  title = {Daily administration of low-dose daunorubicin or doxorubicin inhibits hypoxia-inducible factor 1 and tumor vascularization},
  author = {Yang, Y. and Chen, D. Z. and Rey, S. and Liu, J. O. and Semenza, G. L.},
  year = {2022},
  doi = {10.1101/2022.06.15.492526},
  url = {https://www.biorxiv.org/content/10.1101/2022.06.15.492526v1},
  note = {Source identifier: 10.1101/2022.06.15.492526}
}